Ultragenyx Pharmaceutical (RARE) Cash & Equivalents (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.43% |
| Dec 31, 2025 | 107.89% |
| Sep 30, 2025 | 14.86% |
| Jun 30, 2025 | 38.82% |
| Mar 31, 2025 | -27.01% |
| Dec 31, 2024 | 15.52% |
| Sep 30, 2024 | -68.67% |
| Jun 30, 2024 | 328.23% |
| Mar 31, 2024 | -47.55% |
| Dec 31, 2023 | 194.87% |
| Sep 30, 2023 | -28.89% |
| Jun 30, 2023 | 18.99% |
| Mar 31, 2023 | -35.49% |
| Dec 31, 2022 | -66.06% |
| Sep 30, 2022 | 144.98% |
| Jun 30, 2022 | 3.82% |
| Mar 31, 2022 | -49.94% |
| Dec 31, 2021 | 55.71% |
| Sep 30, 2021 | -32.09% |
| Jun 30, 2021 | -24.21% |
| Mar 31, 2021 | -46.21% |
| Dec 31, 2020 | 261.30% |
| Sep 30, 2020 | -41.16% |
| Jun 30, 2020 | 12.56% |
| Mar 31, 2020 | -31.23% |
| Dec 31, 2019 | 253.72% |
| Sep 30, 2019 | -6.67% |
| Jun 30, 2019 | -51.30% |
| Mar 31, 2019 | 137.77% |
| Dec 31, 2018 | 36.74% |
| Sep 30, 2018 | -25.17% |
| Jun 30, 2018 | -51.11% |
| Mar 31, 2018 | 125.63% |
| Dec 31, 2017 | 66.35% |
| Sep 30, 2017 | -33.44% |
| Jun 30, 2017 | -43.10% |
| Mar 31, 2017 | -1.00% |
| Dec 31, 2016 | 13.24% |
| Sep 30, 2016 | 158.37% |
| Jun 30, 2016 | -22.18% |
| Mar 31, 2016 | -24.37% |
| Dec 31, 2015 | -43.87% |
| Sep 30, 2015 | 218.40% |
| Jun 30, 2015 | -70.60% |
| Mar 31, 2015 | 631.95% |
| Dec 31, 2014 | -54.44% |
| Sep 30, 2014 | 205.91% |
| Jun 30, 2014 | -68.52% |
| Mar 31, 2014 | 646.56% |
| Dec 31, 2013 | 22.78% |
| Sep 30, 2013 | -55.22% |
| Jun 30, 2013 | -79.16% |